Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA

被引：0
|
作者：
Lyakishev, AA
机构：
来源：
KARDIOLOGIYA | 2004年 / 44卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [1] Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial
    Chaitman, BR
    Pepine, CJ
    Parker, JO
    Skopal, J
    Chumakova, G
    Kuch, J
    Wang, WD
    Skettino, SL
    Wolff, AA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (03): : 309 - 316
  • [2] Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial
    Lopez Sendon, Jose
    Lee, Stella
    Cheng, Mei L.
    Ben-Yehuda, Ori
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (05) : 952 - 959
  • [3] Rebound worsening in exercise performance was not observed after abrupt ranolazine withdrawal in patients with chronic angina in CARISA
    Parker, JO
    Chaitman, B
    Skopal, J
    Chumakova, G
    Kuch, J
    Wang, W
    Skettino, S
    Wolff, A
    EUROPEAN HEART JOURNAL, 2003, 24 : 20 - 20
  • [4] Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes
    Timmis, AD
    Chaitman, BR
    Crager, M
    EUROPEAN HEART JOURNAL, 2006, 27 (01) : 42 - 48
  • [5] EFFECTS OF A NEW METABOLIC MODULATOR, RANOLAZINE, ON EXERCISE TOLERANCE IN ANGINA-PECTORIS PATIENTS TREATED WITH BETA-BLOCKER OR DILTIAZEM
    COCCO, G
    ROUSSEAU, MF
    BOUVY, T
    CHERON, P
    WILLIAMS, G
    DETRY, JM
    POULEUR, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (01) : 131 - 138
  • [6] Ranolazine as add-on therapy for patients with severe chronic angina
    Hooper, JS
    Busti, AJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (16): : 1959 - 1959
  • [7] Safety and tolerability of ranolazine and HMG coa reductase inhibitors (statins) in patients with chronic angina.
    Parker, J. O.
    Crager, M. R.
    Jerling, M.
    Koren, A. T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S105 - S105
  • [8] Prognostic effects of benidipine in patients with vasospastic angina: Comparison with diltiazem and amlodipine
    Fukumoto, Yoshihiro
    Yasuda, Satoshi
    Ito, Akira
    Shimokawa, Hiroaki
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 51 (03) : 253 - 257
  • [9] Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina. Results from the TERISA randomized clinical trial (Type 2 diabetes Evaluation of Ranolazine In subjects with chronic Stable Angina)
    Kosiborod, M.
    Arnold, S. V.
    Spertus, J. A.
    McGuire, D. K.
    Li, Y.
    Yue, P.
    Ben-Yehuda, O.
    Katz, A.
    Jones, P. G.
    Olmsted, A.
    Belardinelli, L.
    Chaitman, B. R.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (03) : 323 - 332
  • [10] Discordant effects of amlodipine on exercise-induced vs mental stress induced myocardial ischemia in patients with angina.
    Jain, D
    Burg, M
    Soufer, R
    Wackers, FJT
    Zaret, BL
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 225 - 225
12345